Aurora Therapeutics, cofounded by Nobel Prize–winning scientist Jennifer Doudna, plans to use gene editing and a new FDA ...
Here at MIT Technology Review we’ve been writing about the gene-editing technology CRISPR since 2013, calling it the biggest ...
A patient death in a CRISPR trial halts gene editing studies, raising critical safety questions. What this means for the ...
Aurora Therapeutics today announced its official launch to transform personalized gene editing from a one-patient breakthrough into a scalable model capable of bringing therapies to millions of ...
As CRISPR moves from lab success to real-world medicine, 2026 will test whether these revolutionary gene-editing therapies ...
Like other developing countries, Indonesia is facing a familiar dilemma: how to feed a growing population while protecting ...
Canada is wrestling with how gene-editing should translate to voluntary genetically modified food labels, or whether it even ...
Three start-ups are aiming to create gene-edited babies. Columnist Michael Le Page has no doubt that editing our offspring ...
On the final trading day of 2025, Cathie Wood put an eye-brow raising $1.33 million to work in Intellia Therapeutics ( NTLA ) ...
12don MSNOpinion
Cathie Wood invests heavily in gene-editing companies, offloads $30 million worth Tesla stock
Cathie Wood’s Ark Invest increased exposure to gene-editing names and autonomous mobility companies while further cutting ...
This article is the third in a series that U.S. News & World Report will publish on six major investing megatrends taking shape over the next decade. To discern which ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback